30496485|t|PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
30496485|a|Coiled-coil-helix-coiled-coil-helix domain containing protein 2 (CHCHD2) mutations were linked with autosomal dominant Parkinson's disease (PD) and recently, Alzheimer's disease/frontotemporal dementia. In the current study, we generated isogenic human embryonic stem cell (hESC) lines harboring PD-associated CHCHD2 mutation R145Q or Q126X via clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) method, aiming to unravel pathophysiologic mechanism and seek potential intervention strategy against CHCHD2 mutant-caused defects. By engaging super-resolution microscopy, we identified a physical proximity and similar distribution pattern of CHCHD2 along mitochondria with mitochondrial contact site and cristae organizing system (MICOS), a large protein complex maintaining mitochondria cristae. Isogenic hESCs and differentiated neural progenitor cells (NPCs) harboring CHCHD2 R145Q or Q126X mutation showed impaired mitochondria function, reduced CHCHD2 and MICOS components and exhibited nearly hollow mitochondria with reduced cristae. Furthermore, PD-linked CHCHD2 mutations lost their interaction with coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10), while transient knockdown of either CHCHD2 or CHCHD10 reduced MICOS and mitochondria cristae. Importantly, a specific mitochondria-targeted peptide, Elamipretide/MTP-131, now tested in phase 3 clinical trials for mitochondrial diseases, was found to enhance CHCHD2 with MICOS and mitochondria oxidative phosphorylation enzymes in isogenic NPCs harboring heterozygous R145Q, suggesting that Elamipretide is able to attenuate CHCHD2 R145Q-induced mitochondria dysfunction. Taken together, our results suggested CHCHD2-CHCHD10 complex may be a novel therapeutic target for PD and related neurodegenerative disorders, and Elamipretide may benefit CHCHD2 mutation-linked PD.
30496485	0	2	PD	Disease	MESH:D010300
30496485	10	16	CHCHD2	Gene	51142
30496485	34	41	CHCHD10	Gene	400916
30496485	71	95	mitochondria dysfunction	Disease	MESH:C564971
30496485	97	160	Coiled-coil-helix-coiled-coil-helix domain containing protein 2	Gene	51142
30496485	162	168	CHCHD2	Gene	51142
30496485	216	235	Parkinson's disease	Disease	MESH:D010300
30496485	237	239	PD	Disease	MESH:D010300
30496485	255	274	Alzheimer's disease	Disease	MESH:D000544
30496485	275	298	frontotemporal dementia	Disease	MESH:D057180
30496485	344	349	human	Species	9606
30496485	393	395	PD	Disease	MESH:D010300
30496485	407	413	CHCHD2	Gene	51142
30496485	423	428	R145Q	ProteinMutation	tmVar:p|SUB|R|145|Q;HGVS:p.R145Q;VariantGroup:1;CorrespondingGene:51142;RS#:752169833;CorrespondingSpecies:9606;CA#:214827
30496485	432	437	Q126X	ProteinMutation	tmVar:p|SUB|Q|126|X;HGVS:p.Q126X;VariantGroup:0;CorrespondingGene:51142;RS#:763704645;CorrespondingSpecies:9606;CA#:4270509
30496485	646	652	CHCHD2	Gene	51142
30496485	788	794	CHCHD2	Gene	51142
30496485	1018	1024	CHCHD2	Gene	51142
30496485	1025	1030	R145Q	ProteinMutation	tmVar:p|SUB|R|145|Q;HGVS:p.R145Q;VariantGroup:1;CorrespondingGene:51142;RS#:752169833;CorrespondingSpecies:9606;CA#:214827
30496485	1034	1039	Q126X	ProteinMutation	tmVar:p|SUB|Q|126|X;HGVS:p.Q126X;VariantGroup:0;CorrespondingGene:51142;RS#:763704645;CorrespondingSpecies:9606;CA#:4270509
30496485	1096	1102	CHCHD2	Gene	51142
30496485	1200	1202	PD	Disease	MESH:D010300
30496485	1210	1216	CHCHD2	Gene	51142
30496485	1321	1328	CHCHD10	Gene	400916
30496485	1367	1373	CHCHD2	Gene	51142
30496485	1377	1384	CHCHD10	Gene	400916
30496485	1480	1492	Elamipretide	Chemical	MESH:C506540
30496485	1493	1500	MTP-131	Chemical	MESH:C506540
30496485	1544	1566	mitochondrial diseases	Disease	MESH:D028361
30496485	1589	1595	CHCHD2	Gene	51142
30496485	1698	1703	R145Q	ProteinMutation	tmVar:p|SUB|R|145|Q;HGVS:p.R145Q;VariantGroup:1;CorrespondingGene:51142;RS#:752169833;CorrespondingSpecies:9606;CA#:214827
30496485	1721	1733	Elamipretide	Chemical	MESH:C506540
30496485	1755	1761	CHCHD2	Gene	51142
30496485	1762	1767	R145Q	ProteinMutation	tmVar:p|SUB|R|145|Q;HGVS:p.R145Q;VariantGroup:1;CorrespondingGene:51142;RS#:752169833;CorrespondingSpecies:9606;CA#:214827
30496485	1776	1800	mitochondria dysfunction	Disease	MESH:C564971
30496485	1840	1846	CHCHD2	Gene	51142
30496485	1847	1854	CHCHD10	Gene	400916
30496485	1901	1903	PD	Disease	MESH:D010300
30496485	1916	1943	neurodegenerative disorders	Disease	MESH:D019636
30496485	1949	1961	Elamipretide	Chemical	MESH:C506540
30496485	1974	1980	CHCHD2	Gene	51142
30496485	1997	1999	PD	Disease	MESH:D010300
30496485	Association	MESH:D010300	RS#:752169833;HGVS:p.R145Q;CorrespondingGene:51142
30496485	Association	MESH:D010300	RS#:763704645;HGVS:p.Q126X;CorrespondingGene:51142
30496485	Association	MESH:D000544	51142
30496485	Association	MESH:D019636	400916
30496485	Positive_Correlation	MESH:C564971	RS#:752169833;HGVS:p.R145Q;CorrespondingGene:51142
30496485	Negative_Correlation	MESH:C506540	MESH:D028361
30496485	Negative_Correlation	MESH:C506540	RS#:752169833;HGVS:p.R145Q;CorrespondingGene:51142
30496485	Association	MESH:D019636	51142
30496485	Bind	400916	51142
30496485	Association	MESH:D028361	51142
30496485	Negative_Correlation	MESH:C506540	51142
30496485	Association	MESH:D057180	51142
30496485	Association	MESH:D010300	51142
30496485	Association	MESH:C564971	51142
30496485	Association	MESH:C564971	400916
30496485	Association	MESH:D010300	400916
30496485	Negative_Correlation	MESH:C506540	MESH:C564971
30496485	Association	MESH:D010300	51142
30496485	Association	MESH:C564971	51142

